Fresenius Medical Care AG (FMCQF) EBITDA (2009 - 2025)

Fresenius Medical Care AG's EBITDA history runs 17 years deep, the most recent figure standing at $1.1 billion for Q4 2025.

• In Q4 2025, EBITDA rose 43.12% year-over-year to $1.1 billion; the TTM figure through Dec 2025 stood at $3.4 billion (down 1.2% YoY), while the FY2025 annual figure was $4.4 billion, up 20.51% from the prior year.
• EBITDA was $1.1 billion for Q4 2025 at Fresenius Medical Care AG, up from $557.1 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $1.1 billion in Q4 2025 to a low of $557.1 million in Q3 2025.
• Historically, EBITDA has averaged $887.8 million across 5 years, with a median of $869.3 million in 2022.
• Biggest YoY gain for EBITDA was 43.12% in 2025; the steepest drop was 38.74% in 2025.
• A 5-year view of EBITDA shows it stood at $1.0 billion in 2021, then dropped by 14.74% to $864.1 million in 2022, then advanced by 6.33% to $918.9 million in 2023, then fell by 14.41% to $786.5 million in 2024, then surged by 43.12% to $1.1 billion in 2025.
• The last three EBITDA figures came in at $1.1 billion (Q4 2025), $557.1 million (Q3 2025), and $906.7 million (Q2 2025), per Business Quant data.